I would recomment to check out a drug called OncoVex. They are currently in Phase III and as I have heard from some sources had achieved quite some remarkable results while OncoVex has only a benign side effect profile. Biovex which is developing OncoVex has just been sold for $1bn to Amgen based on most recent data from the phIII study.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.